|
| | Bupivacaine Hydrochloride Basic information |
| Product Name: | Bupivacaine Hydrochloride | | Synonyms: | Bupivacaine Hydrochloride (500 mg);1-Butyl-N-(2,6-dimethylphenyl)-2-piperidinecarboxamide hydrochloride hydrate;bupivacaine hydrochloride hydrate;Bupivacaine HCl hydrate;1-Butyl-N-(2,6-dimethylphenyl)piperidine-2-carboxamide hydrochloride hydrate;2-Piperidinecarboxamide, 1-butyl-N-(2,6-dimethylphenyl)-, hydrochloride, hydrate (1:1:1);1-butyl-N-(2,6-dimethylphenyl)-2-Piperidinecarboxamide hydrochloride hydrate (1:1:1) | | CAS: | 73360-54-0 | | MF: | C18H31ClN2O2 | | MW: | 342.91 | | EINECS: | 642-205-3 | | Product Categories: | | | Mol File: | 73360-54-0.mol |  |
| | Bupivacaine Hydrochloride Chemical Properties |
| Melting point | 255-259℃ | | RTECS | TK6125000 | | storage temp. | room temp | | solubility | DMSO (Slightly), Methanol (Slightly), Water (Slightly) | | form | neat | | Water Solubility | Soluble in water to 50 mM, in DMSO to 100 mM and in ethanol to 100 mM. |
| Hazard Codes | T+ | | Risk Statements | 26/27/28 | | Safety Statements | 22-36/37/39-45 | | RIDADR | UN 2811 6.1 / PGII | | WGK Germany | 3 | | HazardClass | 6.1 |
| | Bupivacaine Hydrochloride Usage And Synthesis |
| Uses | It is employed as Na+ channel blocker, local anesthetic and cAMP production inhibitor. It acts as a surfactant molecule possessing both hydrophilic and lipophilic properties, adrenergic antagonist, EC 3.1.1.8 (cholinesterase) inhibitor and EC 3.6.3.8 (Ca(2+)-transporting ATPase) inhibitor. | | Definition | ChEBI: A racemate composed of equimolar amounts of dextrobupivacaine hydrochloride hydrate and levobupivacaine hydrochloride hydrate. A piperidinecarboxamide-based local anaesthetic, it has a slow onset and long duration of action. |
| | Bupivacaine Hydrochloride Preparation Products And Raw materials |
|
